The American Society of Breast Surgeons reported that it has completed enrollment of its MammoSite Patient Registry, a U.S. data collection program designed to analyze the efficacy of accelerated partial breast irradiation with the MammoSite balloon catheter device from radiation therapy developer Proxima Therapeutics of Alpharetta, GA.
The Society said it has successfully achieved its goal of enrolling 1,500 patients in the study, and has initiated analysis of that data. Preliminary findings including demographics, cosmetic results, and toxicity will be presented this December at the Breast Cancer Symposium in San Antonio, TX.
By AuntMinnie.com staff writers
October 12, 2004
Related Reading
Proxima gets FDA OK for new MammoSite, September 22, 2004
Varian, Proxima team up for partial breast irradiation, July 7, 2004
Proxima touts MammoSite research, May 17, 2004
Proxima receives clearance for new MammoSite catheters, April 1, 2004
MammoSite RTS treats first Canadian patient, September 17, 2003
Copyright © 2004 AuntMinnie.com
